The global bispecific and multispecific antibodies market is experiencing substantial growth, driven by rising demand for innovative therapies. These antibody formats offer significant therapeutic potential by concurrently targeting two antigens, leading to optimized efficacy and minimized side effects. Leading players in the market are actively in